Considering the difficulties of the current therapeutic method in eradicating keloid and the potential role of NPTX2 inhibition in keloid formation, we proposed the development of NPTX2 agonist might represent a novel option for keloid clinical treatment. The gene discussed is NPTX2; the disease is keloid.